Which statement best describes a depot medication?

A. To improve mental alertness and focus: Kava does not enhance alertness or cognitive focus. In fact, it has sedative properties that may cause drowsiness, making it unsuitable for improving attention or concentration.

B. To lower cholesterol and triglycerides: Kava has no established lipid-lowering effects. Herbal remedies for cholesterol management typically include garlic or red yeast rice, not kava, which primarily acts on the central nervous system.

C. To reduce muscle cramps and injury: Kava does not have muscle relaxant or anti-inflammatory properties effective for treating cramps or preventing injuries. Its mechanism targets anxiety and sleep regulation rather than musculoskeletal issues.

D. To promote sleep and reduce anxiety: Kava is commonly used as an herbal supplement for its anxiolytic and sedative effects. It enhances GABA receptor activity in the brain, helping reduce anxiety, promote relaxation, and improve sleep quality.

A. An adverse medication effect resulting in blistering and peeling of skin: Stevens-Johnson syndrome is a rare but severe hypersensitivity reaction often triggered by medications. It is characterized by painful blistering, peeling of the skin, and involvement of mucous membranes.

B. An adverse medication effect resulting in a yellow discoloration of the eyes: Yellowing of the eyes indicates jaundice, which is commonly linked to hepatotoxicity. While some drugs can cause liver injury, this finding does not describe Stevens-Johnson syndrome.

C. An adverse medication effect resulting in nephrotoxicity and reduced urine output: Nephrotoxicity is kidney-related damage that reduces renal function. Certain drugs such as aminoglycosides can cause this, but it is unrelated to the dermatologic presentation of Stevens-Johnson syndrome.

D. An adverse medication effect resulting in pulmonary toxicity and hypoxemia: Pulmonary toxicity can occur with medications such as amiodarone, leading to hypoxemia, but this does not describe Stevens-Johnson syndrome, which primarily affects the skin and mucous membranes.